Prostate cancer prognosis linked to prostate-specific antigen levels below threshold
After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an indicator that treatment is working. A recent real-world study indicates that reaching a PSA level below 0.2 ng/mL is an indicator of improved patient survival. The study is published online in CANCER.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.